Melasma Segment by Condition to Account Larger Share in Hyperpigmentation Disorder Treatment Market during 2022-2030
According to our latest study on "Hyperpigmentation Disorder Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis" the market is expected to grow from US$ 6.68 billion in 2022 and is expected to reach US$ 11.78 billion by 2030; it is anticipated to record a CAGR of 7.4% from 2022 to 2030. The report highlights the key factors driving the hyperpigmentation disorder treatment market growth and prominent players with their developments in the market.
Hyperpigmentation disorder treatment market involves intradermal or subcutaneous injections of pharmaceutical preparations, enzymes, hormones, plant extracts, vitamins, and/or other ingredients such as hyaluronic acid. Factors such as simplified and minimally invasive procedures, and wide range of applications and improvements in comfort, efficiency, and outcomes with technological advancements propel the hyperpigmentation disorder treatment market growth. However, the potential side effects and regulatory challenges hampers the growth of the market.
By treatment type, the market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest hyperpigmentation disorder treatment market share in 2022. Cosmeceuticals, which harness both cosmetic and pharmaceutical capabilities, have gained significant attention in skincare, particularly in addressing concerns such as hyperpigmentation. Potent active pharmaceutical ingredients are combined with cosmetic formulations to effectively target specific skin issues. For the treatment of hyperpigmentation, the effect of cosmeceuticals goes beyond traditional skincare products to lighten dark spots, even out skin tone, and enhance skin radiance. Ingredients such as vitamin C, niacinamide, kojic acid, and alpha hydroxy acids are commonly found in cosmeceutical formulations designed for hyperpigmentation, offering brightening and pigment-regulating properties. Combining advanced pharmaceutical ingredients into cosmeceutical formulations provides targeted treatment approaches that help address issues associated with melanin production, skin discoloration, and uneven pigmentation, thereby promoting a more balanced and radiant complexion.
The market, by condition, is categorized into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest hyperpigmentation disorder treatment market share in 2022. It is further anticipated to register the highest CAGR during the forecast period. The market, by end user, is categorized into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022. Further, the dermatology centers segment is anticipated to register the highest CAGR during the forecast period.
The market, by end user, is categorized into dermatology clinics, hospitals, cosmetic clinics, and others. The dermatology clinics segment held the largest share of the hyperpigmentation disorder treatment market in 2022, and it is anticipated to register the highest CAGR during the forecast period. Patients with specialized dermatology treatment needs tend to visit dermatology clinics for rapid and effective services. These patients usually have specific skin or hair conditions that require expert evaluation and management. Dermatologists are trained to diagnose and treat various skin issues, such as acne, eczema, psoriasis, aging skin, hyperpigmentation, and hair loss. Hyperpigmentation disorder treatment treatments offered in dermatology clinics are tailored to address these specific concerns, with customized formulations designed to target the underlying causes of skin or hair problems. Dermatologists' expertise and specialized knowledge in diagnosing and treating skin conditions stand as one of the primary advantages of receiving hyperpigmentation disorder treatment treatments at dermatology clinics.
AbbVie Inc, Bayer AG, Epipharm AG, Galderma Laboratories, Obagi Cosmeceuticals LLC, Lutronic Corporation, La Pristine, L'oreal S.A, Pierre Fabre Group, and Vivier Pharma USA are among the leading companies operating in the global hyperpigmentation disorder treatment market.
Companies operating in the hyperpigmentation disorder treatment market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the hyperpigmentation disorder treatment market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall hyperpigmentation disorder treatment market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
A few of the significant developments by key market players are listed below.